Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Lovastatin protects against experimental plague in mice.

Ayyadurai S, Lepidi H, Nappez C, Raoult D, Drancourt M.

PLoS One. 2010 Jun 2;5(6):e10928. doi: 10.1371/journal.pone.0010928.

2.

Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.

Rosenzweig JA, Brackman SM, Kirtley ML, Sha J, Erova TE, Yeager LA, Peterson JW, Xu ZQ, Chopra AK.

Antimicrob Agents Chemother. 2011 Nov;55(11):5034-42. doi: 10.1128/AAC.00632-11. Epub 2011 Aug 22.

3.

Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

Zauberman A, Tidhar A, Levy Y, Bar-Haim E, Halperin G, Flashner Y, Cohen S, Shafferman A, Mamroud E.

PLoS One. 2009 Jun 16;4(6):e5938. doi: 10.1371/journal.pone.0005938.

4.

Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge.

Sofer-Podesta C, Ang J, Hackett NR, Senina S, Perlin D, Crystal RG, Boyer JL.

Infect Immun. 2009 Apr;77(4):1561-8. doi: 10.1128/IAI.00856-08. Epub 2009 Jan 5.

5.

In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.

Wendte JM, Ponnusamy D, Reiber D, Blair JL, Clinkenbeard KD.

Antimicrob Agents Chemother. 2011 Aug;55(8):3752-7. doi: 10.1128/AAC.01481-10. Epub 2011 May 31.

6.

Long-term persistence of virulent Yersinia pestis in soil.

Ayyadurai S, Houhamdi L, Lepidi H, Nappez C, Raoult D, Drancourt M.

Microbiology. 2008 Sep;154(Pt 9):2865-71. doi: 10.1099/mic.0.2007/016154-0.

PMID:
18757820
7.

Cell-mediated protection against pulmonary Yersinia pestis infection.

Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK, Smiley ST.

Infect Immun. 2005 Nov;73(11):7304-10.

8.
9.

A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.

Oyston PC, Mellado-Sanchez G, Pasetti MF, Nataro JP, Titball RW, Atkins HS.

Microb Pathog. 2010 May;48(5):191-5. doi: 10.1016/j.micpath.2010.01.005. Epub 2010 Jan 22.

10.

Expression profiling of Yersinia pestis during mouse pulmonary infection.

Lawson JN, Lyons CR, Johnston SA.

DNA Cell Biol. 2006 Nov;25(11):608-16.

PMID:
17132091
11.

[Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain].

Ryzhko IV, Tsuraeva RI, Moldavan IA, Shcherbaniuk AI.

Antibiot Khimioter. 2004;49(1):17-21. Russian.

PMID:
15164519
12.

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

Lin JS, Kummer LW, Szaba FM, Smiley ST.

J Immunol. 2011 Feb 1;186(3):1675-84. doi: 10.4049/jimmunol.1003303. Epub 2010 Dec 20.

13.

Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

Louie A, Heine HS, VanScoy B, Eichas A, Files K, Fikes S, Brown DL, Liu W, Kinzig-Schippers M, Sörgel F, Drusano GL.

Antimicrob Agents Chemother. 2011 Feb;55(2):822-30. doi: 10.1128/AAC.00818-10. Epub 2010 Nov 29.

14.

An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.

Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2012;6(2):e1528. doi: 10.1371/journal.pntd.0001528. Epub 2012 Feb 14.

15.
16.
17.

Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model.

Xiao X, Zhu Z, Dankmeyer JL, Wormald MM, Fast RL, Worsham PL, Cote CK, Amemiya K, Dimitrov DS.

PLoS One. 2010 Oct 13;5(10):e13047. doi: 10.1371/journal.pone.0013047.

18.

The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection.

Tanabe M, Atkins HS, Harland DN, Elvin SJ, Stagg AJ, Mirza O, Titball RW, Byrne B, Brown KA.

Infect Immun. 2006 Jun;74(6):3687-91.

19.

Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis.

Lee-Lewis H, Anderson DM.

Infect Immun. 2010 Jan;78(1):220-30. doi: 10.1128/IAI.00559-09. Epub 2009 Oct 19.

20.

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.

Vagima Y, Zauberman A, Levy Y, Gur D, Tidhar A, Aftalion M, Shafferman A, Mamroud E.

PLoS Pathog. 2015 May 14;11(5):e1004893. doi: 10.1371/journal.ppat.1004893. eCollection 2015 May.

Supplemental Content

Support Center